Skip to main content
NCBI home page
Protein & Cell logoLink to Protein & Cell
. 2010 Feb 7;1(1):33–47. doi: 10.1007/s13238-010-0002-5

The role of ADAMTSs in arthritis

Edward A Lin 1, Chuan-Ju Liu 1,2,✉
PMCID: PMC4418016  NIHMSID: NIHMS681651  PMID: 21203996

Abstract

The ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family consists of 19 proteases. These enzymes are known to play important roles in development, angiogenesis and coagulation; dysregulation and mutation of these enzymes have been implicated in many disease processes, such as inflammation, cancer, arthritis and atherosclerosis. This review briefly summarizes the structural organization and functional roles of ADAMTSs in normal and pathological conditions, focusing on members that are known to be involved in the degradation of extracellular matrix and loss of cartilage in arthritis, including the aggrecanases (ADAMTS-4 and ADAMTS-5), ADAMTS-7 and ADAMTS-12, the latter two are associated with cartilage oligomeric matrix protein (COMP), a component of the cartilage extracellular matrix (ECM). We will discuss the expression pattern and the regulation of these metalloproteinases at multiple levels, including their interaction with substrates, induction by pro-inflammatory cytokines, protein processing, inhibition (e.g., TIMP-3, alpha-2-macroglobulin, GEP), and activation (e.g., syndecan-4, PACE-4).

Keywords: ADAMTS, metalloproteinase, aggrecan, COMP, arthritis

References

  1. Ahmad R., Sylvester J., Ahmad M., Zafarullah M. Adaptor proteins and Ras synergistically regulate IL-1-induced ADAMTS-4 expression in human chondrocytes. J Immunol. 2009;182:5081–5087. doi: 10.4049/jimmunol.0803544. [DOI] [PubMed] [Google Scholar]
  2. Anakwe O.O., Gerton G.L. Acrosome biogenesis begins during meiosis: evidence from the synthesis and distribution of an acrosomal glycoprotein, acrogranin, during guinea pig spermatogenesis. Biol Reprod. 1990;42:317–328. doi: 10.1095/biolreprod42.2.317. [DOI] [PubMed] [Google Scholar]
  3. Apte S.S. A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motifs: the ADAMTS family. Int J Biochem Cell Biol. 2004;36:981–985. doi: 10.1016/j.biocel.2004.01.014. [DOI] [PubMed] [Google Scholar]
  4. Apte S.S. A disintegrin-like and metalloprotease (reprolysin-type) with hrombospondin type 1 motif (ADAMTS) superfamily-functions and mechanisms. J Biol Chem. 2009;284:31493–31497. doi: 10.1074/jbc.R109.052340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Arner E.C., Pratta M.A., Trzaskos J.M., Decicco C.P., Tortorella M.D. Generation and characterization of aggrecanase. A soluble, cartilage-derived aggrecan-degrading activity. J Biol Chem. 1999;274:6594–6601. doi: 10.1074/jbc.274.10.6594. [DOI] [PubMed] [Google Scholar]
  6. Bai, X.H., Wang, D.W., Kong, L., Zhang, Y., Luan, Y., Kobayashi, T., Kronenberg, H.M., Yu, X.P., and Liu, C.J. (2009). ADAMTS-7, a Direct Target of PTHrP, Adversely Regulates Endochondral Bone Growth via Associating with and Inactivating GEP Growth Factor. Mol Cell Biol. In press. [DOI] [PMC free article] [PubMed]
  7. Baker A.H., Edwards D.R., Murphy G. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci. 2002;115:3719–3727. doi: 10.1242/jcs.00063. [DOI] [PubMed] [Google Scholar]
  8. Barreda D.R., Hanington P.C., Walsh C.K., Wong P., Belosevic M. Differentially expressed genes that encode potential markers of goldfish macrophage development in vitro. Dev Comp Immunol. 2004;28:727–746. doi: 10.1016/j.dci.2003.11.005. [DOI] [PubMed] [Google Scholar]
  9. Basile D.P., Fredrich K., Chelladurai B., Leonard E.C., Parrish A.R. Renal ischemia reperfusion inhibits VEGF expression and induces ADAMTS-1, a novel VEGF inhibitor. Am J Physiol Renal Physiol. 2008;294:F928–936. doi: 10.1152/ajprenal.00596.2007. [DOI] [PubMed] [Google Scholar]
  10. Bau B., Gebhard P.M., Haag J., Knorr T., Bartnik E., Aigner T. Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. Arthritis Rheum. 2002;46:2648–2657. doi: 10.1002/art.10531. [DOI] [PubMed] [Google Scholar]
  11. Behera A.K., Hildebrand E., Szafranski J., Hung H.H., Grodzinsky A.J., Lafyatis R., Koch A.E., Kalish R., Perides G., Steere A.C., et al. Role of aggrecanase 1 in Lyme arthritis. Arthritis Rheum. 2006;54:3319–3329. doi: 10.1002/art.22128. [DOI] [PubMed] [Google Scholar]
  12. Bergeron F., Leduc R., Day R. Subtilase-like pro-protein convertases: from molecular specificity to therapeutic applications. J Mol Endocrinol. 2000;24:1–22. doi: 10.1677/jme.0.0240001. [DOI] [PubMed] [Google Scholar]
  13. Bevitt D.J., Mohamed J., Catterall J.B., Li Z., Arris C.E., Hiscott P., Sheridan C., Langton K.P., Barker M.D., Clarke M.P., et al. Expression of ADAMTS metalloproteinases in the retinal pigment epithelium derived cell line ARPE-19: transcriptional regulation by TNFalpha. Biochim Biophys Acta. 2003;1626:83–91. doi: 10.1016/s0167-4781(03)00047-2. [DOI] [PubMed] [Google Scholar]
  14. Bondeson J., Wainwright S., Hughes C., Caterson B. The regulation of the ADAMTS4 and ADAMTS5 aggrecanases in osteoarthritis: a review. Clin Exp Rheumatol. 2008;26:139–145. [PubMed] [Google Scholar]
  15. Bondeson J., Wainwright S.D., Lauder S., Amos N., Hughes C.E. The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis. Arthritis Res Ther. 2006;8:R187. doi: 10.1186/ar2099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Briggs M.D., Hoffman S.M., King L.M., Olsen A.S., Mohrenweiser H., Leroy J.G., Mortier G.R., Rimoin D.L., Lachman R.S., Gaines E.S., et al. Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene. Nat Genet. 1995;10:330–336. doi: 10.1038/ng0795-330. [DOI] [PubMed] [Google Scholar]
  17. Briggs M.D., Mortier G.R., Cole W.G., King L.M., Golik S.S., Bonaventure J., Nuytinck L., De Paepe A., Leroy J.G., Biesecker L., et al. Diverse mutations in the gene for cartilage oligomeric matrix protein in the pseudoachondroplasia-multiple epiphyseal dysplasia disease spectrum. Am J Hum Genet. 1998;62:311–319. doi: 10.1086/301713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Brown H.M., Dunning K.R., Robker R.L., Pritchard M., Russell D.L. Requirement for ADAMTS-1 in extracellular matrix remodeling during ovarian folliculogenesis and lymphangiogenesis. Dev Biol. 2006;300:699–709. doi: 10.1016/j.ydbio.2006.10.012. [DOI] [PubMed] [Google Scholar]
  19. Burrage P.S., Mix K.S., Brinckerhoff C.E. Matrix metalloproteinases: role in arthritis. Front Biosci. 2006;11:529–543. doi: 10.2741/1817. [DOI] [PubMed] [Google Scholar]
  20. Bursavich M.G., Gilbert A.M., Lombardi S., Georgiadis K.E., Reifenberg E., Flannery C.R., Morris E.A. 5′-Phenyl-3′H-spiro[indoline-3,2′-[1,3,4]thiadiazol]-2-one inhibitors of ADAMTS-5 (aggrecanase-2) Bioorg Med Chem Lett. 2007;17:5630–5633. doi: 10.1016/j.bmcl.2007.07.048. [DOI] [PubMed] [Google Scholar]
  21. Bursavich M.G., Gilbert A.M., Lombardi S., Georgiadis K.E., Reifenberg E., Flannery C.R., Morris E.A. Synthesis and evaluation of aryl thioxothiazolidinone inhibitors of ADAMTS-5 (Aggrecanase-2) Bioorg Med Chem Lett. 2007;17:1185–1188. doi: 10.1016/j.bmcl.2006.12.027. [DOI] [PubMed] [Google Scholar]
  22. Cal S., Arguelles J.M., Fernandez P.L., Lopez-Otin C. Identification, characterization, and intracellular processing of ADAM-TS12, a novel human disintegrin with a complex structural organization involving multiple thrombospondin-1 repeats. J Biol Chem. 2001;276:17932–17940. doi: 10.1074/jbc.M100534200. [DOI] [PubMed] [Google Scholar]
  23. Caterson B., Flannery C.R., Hughes C.E., Little C.B. Mechanisms involved in cartilage proteoglycan catabolism. Matrix Biol. 2000;19:333–344. doi: 10.1016/s0945-053x(00)00078-0. [DOI] [PubMed] [Google Scholar]
  24. Chan I., Liu L., Hamada T., Sethuraman G., McGrath J.A. The molecular basis of lipoid proteinosis: mutations in extracellular matrix protein 1. Exp Dermatol. 2007;16:881–890. doi: 10.1111/j.1600-0625.2007.00608.x. [DOI] [PubMed] [Google Scholar]
  25. Chan P.S., Caron J.P., Orth M.W. Short-term gene expression changes in cartilage explants stimulated with interleukin beta plus glucosamine and chondroitin sulfate. J Rheumatol. 2006;33:1329–1340. [PubMed] [Google Scholar]
  26. Chen F.H., Thomas A.O., Hecht J.T., Goldring M.B., Lawler J. Cartilage oligomeric matrix protein/thrombospondin 5 supports chondrocyte attachment through interaction with integrins. J Biol Chem. 2005;280:32655–32661. doi: 10.1074/jbc.M504778200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Chia S.L., Sawaji Y., Burleigh A., McLean C., Inglis J., Saklatvala J., Vincent T. Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses ADAMTS-5 and delays cartilage degradation in murine osteoarthritis. Arthritis Rheum. 2009;60:2019–2027. doi: 10.1002/art.24654. [DOI] [PubMed] [Google Scholar]
  28. Chockalingam P.S., Zeng W., Morris E.A., Flannery C.R. Release of hyaluronan and hyaladherins (aggrecan G1 domain and link proteins) from articular cartilage exposed to ADAMTS-4 (aggrecanase 1) or ADAMTS-5 (aggrecanase 2) Arthritis Rheum. 2004;50:2839–2848. doi: 10.1002/art.20496. [DOI] [PubMed] [Google Scholar]
  29. Chu C.T., Howard G.C., Misra U.K., Pizzo S.V. Alpha 2-macroglobulin: a sensor for proteolysis. Ann N Y Acad Sci. 1994;737:291–307. doi: 10.1111/j.1749-6632.1994.tb44319.x. [DOI] [PubMed] [Google Scholar]
  30. Clark I.M., Parker A.E. Metalloproteinases: their role in arthritis and potential as therapeutic targets. Expert Opin Ther Targets. 2003;7:19–34. doi: 10.1517/14728222.7.1.19. [DOI] [PubMed] [Google Scholar]
  31. Clegg D.O., Reda D.J., Harris C.L., Klein M.A., O’Dell J.R., Hooper M.M., Bradley J.D., Bingham C.O., 3rd, Weisman M.H., Jackson C.G., et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006;354:795–808. doi: 10.1056/NEJMoa052771. [DOI] [PubMed] [Google Scholar]
  32. Cohn D.H., Briggs M.D., King L.M., Rimoin D.L., Wilcox W.R., Lachman R.S., Knowlton R.G. Mutations in the cartilage oligomeric matrix protein (COMP) gene in pseudoachondroplasia and multiple epiphyseal dysplasia. Ann N Y Acad Sci. 1996;785:188–194. doi: 10.1111/j.1749-6632.1996.tb56258.x. [DOI] [PubMed] [Google Scholar]
  33. Colige A., Nuytinck L., Hausser I., van Essen A.J., Thiry M., Herens C., Ades L.C., Malfait F., Paepe A.D., Franck P., et al. Novel types of mutation responsible for the dermatosparactic type of Ehlers-Danlos syndrome (Type VIIC) and common polymorphisms in the ADAMTS2 gene. J Invest Dermatol. 2004;123:656–663. doi: 10.1111/j.0022-202X.2004.23406.x. [DOI] [PubMed] [Google Scholar]
  34. Colige A., Sieron A.L., Li S.W., Schwarze U., Petty E., Wertelecki W., Wilcox W., Krakow D., Cohn D.H., Reardon W., et al. Human Ehlers-Danlos syndrome type VII C and bovine dermatosparaxis are caused by mutations in the procollagen I N-proteinase gene. Am J Hum Genet. 1999;65:308–317. doi: 10.1086/302504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Colige A., Vandenberghe I., Thiry M., Lambert C.A., Van Beeumen J., Li S.W., Prockop D.J., Lapiere C.M., Nusgens B.V. Cloning and characterization of ADAMTS-14, a novel ADAMTS displaying high homology with ADAMTS-2 and ADAMTS-3. J Biol Chem. 2002;277:5756–5766. doi: 10.1074/jbc.M105601200. [DOI] [PubMed] [Google Scholar]
  36. Corps A.N., Jones G.C., Harrall R.L., Curry V.A., Hazleman B.L., Riley G.P. The regulation of aggrecanase ADAMTS-4 expression in human Achilles tendon and tendon-derived cells. Matrix Biol. 2008;27:393–401. doi: 10.1016/j.matbio.2008.02.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Cross A.K., Haddock G., Stock C.J., Allan S., Surr J., Bunning R. A., Buttle D.J., Woodroofe M.N. ADAMTS-1 and -4 are up-regulated following transient middle cerebral artery occlusion in the rat and their expression is modulated by TNF in cultured astrocytes. Brain Res. 2006;1088:19–30. doi: 10.1016/j.brainres.2006.02.136. [DOI] [PubMed] [Google Scholar]
  38. Curtis C.L., Rees S.G., Little C.B., Flannery C.R., Hughes C.E., Wilson C., Dent C.M., Otterness I.G., Harwood J.L., Caterson B. Pathologic indicators of degradation and inflammation in human osteoarthritic cartilage are abrogated by exposure to n-3 fatty acids. Arthritis Rheum. 2002;46:1544–1553. doi: 10.1002/art.10305. [DOI] [PubMed] [Google Scholar]
  39. Davidson B., Alejandro E., Florenes V.A., Goderstad J.M., Risberg B., Kristensen G.B., Trope C.G., Kohn E.C. Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma. Cancer. 2004;100:2139–2147. doi: 10.1002/cncr.20219. [DOI] [PubMed] [Google Scholar]
  40. Demircan K., Hirohata S., Nishida K., Hatipoglu O.F., Oohashi T., Yonezawa T., Apte S.S., Ninomiya Y. ADAMTS-9 is synergistically induced by interleukin-1beta and tumor necrosis factor alpha in OUMS-27 chondrosarcoma cells and in human chondrocytes. Arthritis Rheum. 2005;52:1451–1460. doi: 10.1002/art.21010. [DOI] [PubMed] [Google Scholar]
  41. Di Cesare P.E., Chen F.S., Moergelin M., Carlson C.S., Leslie M. P., Perris R., Fang C. Matrix-matrix interaction of cartilage oligomeric matrix protein and fibronectin. Matrix Biol. 2002;21:461–470. doi: 10.1016/s0945-053x(02)00015-x. [DOI] [PubMed] [Google Scholar]
  42. DiCesare P., Hauser N., Lehman D., Pasumarti S., Paulsson M. Cartilage oligomeric matrix protein (COMP) is an abundant component of tendon. FEBS Lett. 1994;354:237–240. doi: 10.1016/0014-5793(94)01134-6. [DOI] [PubMed] [Google Scholar]
  43. Dickinson S.C., Vankemmelbeke M.N., Buttle D.J., Rosenberg K., Heinegard D., Hollander A.P. Cleavage of cartilage oligomeric matrix protein (thrombospondin-5) by matrix metalloproteinases and a disintegrin and metalloproteinase with thrombospondin motifs. Matrix Biol. 2003;22:267–278. doi: 10.1016/s0945-053x(03)00034-9. [DOI] [PubMed] [Google Scholar]
  44. Dunn J.R., Reed J.E., du Plessis D.G., Shaw E.J., Reeves P., Gee A.L., Warnke P., Walker C. Expression of ADAMTS-8, a secreted protease with antiangiogenic properties, is down-regulated in brain tumours. Br J Cancer. 2006;94:1186–1193. doi: 10.1038/sj.bjc.6603006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. East C.J., Stanton H., Golub S.B., Rogerson F.M., Fosang A. J. ADAMTS-5 deficiency does not block aggrecanolysis at preferred cleavage sites in the chondroitin sulfate-rich region of aggrecan. J Biol Chem. 2007;282:8632–8640. doi: 10.1074/jbc.M605750200. [DOI] [PubMed] [Google Scholar]
  46. Echtermeyer F., Bertrand J., Dreier R., Meinecke I., Neugebauer K., Fuerst M., Lee Y.J., Song Y.W., Herzog C., Theilmeier G., et al. Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis. Nat Med. 2009;15:1072–1076. doi: 10.1038/nm.1998. [DOI] [PubMed] [Google Scholar]
  47. Flannery C.R., Zeng W., Corcoran C., Collins-Racie L.A., Chockalingam P.S., Hebert T., Mackie S.A., McDonagh T., Crawford T. K., Tomkinson K.N., et al. Autocatalytic cleavage of ADAMTS-4 (Aggrecanase-1) reveals multiple glycosaminoglycan-binding sites. J Biol Chem. 2002;277:42775–42780. doi: 10.1074/jbc.M205309200. [DOI] [PubMed] [Google Scholar]
  48. Fosang A.J., Little C.B. Drug insight: aggrecanases as therapeutic targets for osteoarthritis. Nat Clin Pract Rheumatol. 2008;4:420–427. doi: 10.1038/ncprheum0841. [DOI] [PubMed] [Google Scholar]
  49. Fosang A.J., Rogerson F.M., East C.J., Stanton H. ADAMTS-5: the story so far. Eur Cell Mater. 2008;15:11–26. doi: 10.22203/ecm.v015a02. [DOI] [PubMed] [Google Scholar]
  50. Ganu V., Goldberg R., Peppard J., Rediske J., Melton R., Hu S.I., Wang W., Duvander C., Heinegard D. Inhibition of interleukin-1alpha-induced cartilage oligomeric matrix protein degradation in bovine articular cartilage by matrix metalloproteinase inhibitors: potential role for matrix metalloproteinases in the generation of cartilage oligomeric matrix protein fragments in arthritic synovial fluid. Arthritis Rheum. 1998;41:2143–2151. doi: 10.1002/1529-0131(199812)41:12<2143::AID-ART9>3.0.CO;2-P. [DOI] [PubMed] [Google Scholar]
  51. Gao G., Plaas A., Thompson V.P., Jin S., Zuo F., Sandy J.D. ADAMTS4 (aggrecanase-1) activation on the cell surface involves C-terminal cleavage by glycosylphosphatidyl inositolanchored membrane type 4-matrix metalloproteinase and binding of the activated proteinase to chondroitin sulfate and heparan sulfate on syndecan-1. J Biol Chem. 2004;279:10042–10051. doi: 10.1074/jbc.M312100200. [DOI] [PubMed] [Google Scholar]
  52. Gao G., Westling J., Thompson V.P., Howell T.D., Gottschall P.E., Sandy J.D. Activation of the proteolytic activity of ADAMTS4 (aggrecanase-1) by C-terminal truncation. J Biol Chem. 2002;277:11034–11041. doi: 10.1074/jbc.M107443200. [DOI] [PubMed] [Google Scholar]
  53. Gendron C., Kashiwagi M., Lim N.H., Enghild J.J., Thogersen I.B., Hughes C., Caterson B., Nagase H. Proteolytic activities of human ADAMTS-5: comparative studies with ADAMTS-4. J Biol Chem. 2007;282:18294–18306. doi: 10.1074/jbc.M701523200. [DOI] [PubMed] [Google Scholar]
  54. Glasson S.S., Askew R., Sheppard B., Carito B., Blanchet T., Ma H.L., Flannery C.R., Peluso D., Kanki K., Yang Z., et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature. 2005;434:644–648. doi: 10.1038/nature03369. [DOI] [PubMed] [Google Scholar]
  55. Hadler N.M., Johnson A.M., Spitznagel J.K., Quinet R.J. Protease inhibitors in inflammatory synovial effusions. Ann Rheum Dis. 1981;40:55–59. doi: 10.1136/ard.40.1.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Hashimoto G., Shimoda M., Okada Y. ADAMTS4 (aggrecanase-1) interaction with the C-terminal domain of fibronectin inhibits proteolysis of aggrecan. J Biol Chem. 2004;279:32483–32491. doi: 10.1074/jbc.M314216200. [DOI] [PubMed] [Google Scholar]
  57. Hashimoto T., Wen G., Lawton M.T., Boudreau N.J., Bollen A.W., Yang G.Y., Barbaro N.M., Higashida R.T., Dowd C.F., Halbach V.V., et al. Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations. Stroke. 2003;34:925–931. doi: 10.1161/01.STR.0000061888.71524.DF. [DOI] [PubMed] [Google Scholar]
  58. Hecht J.T., Nelson L.D., Crowder E., Wang Y., Elder F.F., Harrison W.R., Francomano C.A., Prange C.K., Lennon G.G., Deere M., et al. Mutations in exon 17B of cartilage oligomeric matrix protein (COMP) cause pseudoachondroplasia. Nat Genet. 1995;10:325–329. doi: 10.1038/ng0795-325. [DOI] [PubMed] [Google Scholar]
  59. Hedbom E., Antonsson P., Hjerpe A., Aeschlimann D., Paulsson M., Rosa-Pimentel E., Sommarin Y., Wendel M., Oldberg A., Heinegard D. Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage. J Biol Chem. 1992;267:6132–6136. [PubMed] [Google Scholar]
  60. Herrero-Beaumont G., Ivorra J.A., Del Carmen Trabado M., Blanco F.J., Benito P., Martin-Mola E., Paulino J., Marenco J.L., Porto A., Laffon A., et al. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator. Arthritis Rheum. 2007;56:555–567. doi: 10.1002/art.22371. [DOI] [PubMed] [Google Scholar]
  61. Hong S.J., Kang K.W. Purification of granulin-like polypeptide from the blood-sucking leech, Hirudo nipponia. Protein Expr Purif. 1999;16:340–346. doi: 10.1006/prep.1999.1077. [DOI] [PubMed] [Google Scholar]
  62. Hovinga J.A., Studt J.D., Alberio L., Lammle B. von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experience. Semin Hematol. 2004;41:75–82. doi: 10.1053/j.seminhematol.2003.10.008. [DOI] [PubMed] [Google Scholar]
  63. Ilic M.Z., East C.J., Rogerson F.M., Fosang A.J., Handley C.J. Distinguishing aggrecan loss from aggrecan proteolysis in ADAMTS-4 and ADAMTS-5 single and double deficient mice. J Biol Chem. 2007;282:37420–37428. doi: 10.1074/jbc.M703184200. [DOI] [PubMed] [Google Scholar]
  64. Imada K., Lin N., Liu C., Lu A., Chen W., Yano M., Sato T., Ito A. Nobiletin, a citrus polymethoxy flavonoid, suppresses gene expression and production of aggrecanases-1 and -2 in collagen-induced arthritic mice. Biochem Biophys Res Commun. 2008;373:181–185. doi: 10.1016/j.bbrc.2008.05.171. [DOI] [PubMed] [Google Scholar]
  65. Jones G.C., Riley G.P. ADAMTS proteinases: a multidomain, multi-functional family with roles in extracellular matrix turnover and arthritis. Arthritis Res Ther. 2005;7:160–169. doi: 10.1186/ar1783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Jonsson-Rylander A.C., Nilsson T., Fritsche-Danielson R., Hammarstrom A., Behrendt M., Andersson J.O., Lindgren K., Andersson A.K., Wallbrandt P., Rosengren B., et al. Role of ADAMTS-1 in atherosclerosis: remodeling of carotid artery, immunohistochemistry, and proteolysis of versican. Arterioscler Thromb Vasc Biol. 2005;25:180–185. doi: 10.1161/01.ATV.0000150045.27127.37. [DOI] [PubMed] [Google Scholar]
  67. Kashiwagi M., Enghild J.J., Gendron C., Hughes C., Caterson B., Itoh Y., Nagase H. Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing. J Biol Chem. 2004;279:10109–10119. doi: 10.1074/jbc.M312123200. [DOI] [PubMed] [Google Scholar]
  68. Kashiwagi M., Tortorella M., Nagase H., Brew K. TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5) J Biol Chem. 2001;276:12501–12504. doi: 10.1074/jbc.C000848200. [DOI] [PubMed] [Google Scholar]
  69. Kramerova I.A., Kawaguchi N., Fessler L.I., Nelson R.E., Chen Y., Kramerov A.A., Kusche-Gullberg M., Kramer J.M., Ackley B.D., Sieron A.L., et al. Papilin in development; a pericellular protein with a homology to the ADAMTS metalloproteinases. Development. 2000;127:5475–5485. doi: 10.1242/dev.127.24.5475. [DOI] [PubMed] [Google Scholar]
  70. Kraus V.B., Huebner J.L., Fink C., King J.B., Brown S., Vail T.P., Guilak F. Urea as a passive transport marker for arthritis biomarker studies. Arthritis Rheum. 2002;46:420–427. doi: 10.1002/art.10124. [DOI] [PubMed] [Google Scholar]
  71. Kuno K., Okada Y., Kawashima H., Nakamura H., Miyasaka M., Ohno H., Matsushima K. ADAMTS-1 cleaves a cartilage proteoglycan, aggrecan. FEBS Lett. 2000;478:241–245. doi: 10.1016/s0014-5793(00)01854-8. [DOI] [PubMed] [Google Scholar]
  72. Lark M.W., Bayne E.K., Flanagan J., Harper C.F., Hoerrner L.A., Hutchinson N.I., Singer I.I., Donatelli S.A., Weidner J.R., Williams H.R., et al. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints. J Clin Invest. 1997;100:93–106. doi: 10.1172/JCI119526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Levy G.G., Nichols W.C., Lian E.C., Foroud T., McClintick J.N., McGee B.M., Yang A.Y., Siemieniak D.R., Stark K.R., Gruppo R., et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature. 2001;413:488–494. doi: 10.1038/35097008. [DOI] [PubMed] [Google Scholar]
  74. Li Z., Nardi M.A., Li Y.S., Zhang W., Pan R., Dang S., Yee H., Quartermain D., Jonas S., Karpatkin S. C-terminal ADAMTS-18 fragment induces oxidative platelet fragmentation, dissolves platelet aggregates, and protects against carotid artery occlusion and cerebral stroke. Blood. 2009;113:6051–6060. doi: 10.1182/blood-2008-07-170571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Lind T., McKie N., Wendel M., Racey S.N., Birch M.A. The hyalectan degrading ADAMTS-1 enzyme is expressed by osteoblasts and up-regulated at regions of new bone formation. Bone. 2005;36:408–417. doi: 10.1016/j.bone.2004.11.008. [DOI] [PubMed] [Google Scholar]
  76. Little C.B., Meeker C.T., Golub S.B., Lawlor K.E., Farmer P.J., Smith S.M., Fosang A.J. Blocking aggrecanase cleavage in the aggrecan interglobular domain abrogates cartilage erosion and promotes cartilage repair. J Clin Invest. 2007;117:1627–1636. doi: 10.1172/JCI30765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Liu C.J. The role of ADAMTS-7 and ADAMTS-12 in the pathogenesis of arthritis. Nat Clin Pract Rheumatol. 2009;5:38–45. doi: 10.1038/ncprheum0961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Liu C.J., Kong W., Ilalov K., Yu S., Xu K., Prazak L., Fajardo M., Sehgal B., Di Cesare P.E. ADAMTS-7: a metalloproteinase that directly binds to and degrades cartilage oligomeric matrix protein. FASEB J. 2006;20:988–990. doi: 10.1096/fj.05-3877fje. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Liu C.J., Kong W., Xu K., Luan Y., Ilalov K., Sehgal B., Yu S., Howell R.D., Di Cesare P.E. ADAMTS-12 associates with and degrades cartilage oligomeric matrix protein. J Biol Chem. 2006;281:15800–15808. doi: 10.1074/jbc.M513433200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Llamazares M., Cal S., Quesada V., Lopez-Otin C. Identification and characterization of ADAMTS-20 defines a novel subfamily of metalloproteinases-disintegrins with multiple thrombospondin-1 repeats and a unique GON domain. J Biol Chem. 2003;278:13382–13389. doi: 10.1074/jbc.M211900200. [DOI] [PubMed] [Google Scholar]
  81. Llamazares M., Obaya A.J., Moncada-Pazos A., Heljasvaara R., Espada J., Lopez-Otin C., Cal S. The ADAMTS12 metalloproteinase exhibits anti-tumorigenic properties through modulation of the Ras-dependent ERK signalling pathway. J Cell Sci. 2007;120:3544–3552. doi: 10.1242/jcs.005751. [DOI] [PubMed] [Google Scholar]
  82. Lohmander L.S., Ionescu M., Jugessur H., Poole A.R. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis. Arthritis Rheum. 1999;42:534–544. doi: 10.1002/1529-0131(199904)42:3<534::AID-ANR19>3.0.CO;2-J. [DOI] [PubMed] [Google Scholar]
  83. Lu R., Serrero G. Inhibition of PC cell-derived growth factor (PCDGF, epithelin/granulin precursor) expression by antisense PCDGF cDNA transfection inhibits tumorigenicity of the human breast carcinoma cell line MDA-MB-468. Proc Natl Acad Sci U S A. 2000;97:3993–3998. doi: 10.1073/pnas.97.8.3993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Luan Y., Kong L., Howell D.R., Ilalov K., Fajardo M., Bai X.H., Di Cesare P.E., Goldring M.B., Abramson S.B., Liu C.J. Inhibition of ADAMTS-7 and ADAMTS-12 degradation of cartilage oligomeric matrix protein by alpha-2-macroglobulin. Osteoarthritis Cartilage. 2008;16:1413–1420. doi: 10.1016/j.joca.2008.03.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Luque A., Carpizo D.R., Iruela-Arispe M.L. ADAMTS1/METH1 inhibits endothelial cell proliferation by direct binding and sequestration of VEGF165. J Biol Chem. 2003;278:23656–23665. doi: 10.1074/jbc.M212964200. [DOI] [PubMed] [Google Scholar]
  86. Mahmoodi M., Sahebjam S., Smookler D., Khokha R., Mort J. S. Lack of tissue inhibitor of metalloproteinases-3 results in an enhanced inflammatory response in antigen-induced arthritis. Am J Pathol. 2005;166:1733–1740. doi: 10.1016/S0002-9440(10)62483-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Majerus E.M., Zheng X., Tuley E.A., Sadler J.E. Cleavage of the ADAMTS13 propeptide is not required for protease activity. J Biol Chem. 2003;278:46643–46648. doi: 10.1074/jbc.M309872200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Majumdar M.K., Askew R., Schelling S., Stedman N., Blanchet T., Hopkins B., Morris E.A., Glasson S.S. Double-knockout of ADAMTS-4 and ADAMTS-5 in mice results in physiologically normal animals and prevents the progression of osteoarthritis. Arthritis Rheum. 2007;56:3670–3674. doi: 10.1002/art.23027. [DOI] [PubMed] [Google Scholar]
  89. Malemud C.J. Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci. 2006;11:1696–1701. doi: 10.2741/1915. [DOI] [PubMed] [Google Scholar]
  90. Malfait A.M., Arner E.C., Song R.H., Alston J.T., Markosyan S., Staten N., Yang Z., Griggs D.W., Tortorella M.D. Proprotein convertase activation of aggrecanases in cartilage in situ. Arch Biochem Biophys. 2008;478:43–51. doi: 10.1016/j.abb.2008.07.012. [DOI] [PubMed] [Google Scholar]
  91. Malfait A.M., Liu R.Q., Ijiri K., Komiya S., Tortorella M.D. Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage. J Biol Chem. 2002;277:22201–22208. doi: 10.1074/jbc.M200431200. [DOI] [PubMed] [Google Scholar]
  92. Mansson B., Carey D., Alini M., Ionescu M., Rosenberg L.C., Poole A.R., Heinegard D., Saxne T. Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism. J Clin Invest. 1995;95:1071–1077. doi: 10.1172/JCI117753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Martel-Pelletier J., Welsch D.J., Pelletier J.P. Metalloproteases and inhibitors in arthritic diseases. Best Pract Res Clin Rheumato l. 2001;15:805–829. doi: 10.1053/berh.2001.0195. [DOI] [PubMed] [Google Scholar]
  94. Melching L.I., Fisher W.D., Lee E.R., Mort J.S., Roughley P.J. The cleavage of biglycan by aggrecanases. Osteoarthritis Cartilage. 2006;14:1147–1154. doi: 10.1016/j.joca.2006.05.014. [DOI] [PubMed] [Google Scholar]
  95. Misumi K., Vilim V., Hatazoe T., Murata T., Fujiki M., Oka T., Sakamoto H., Carter S.D. Serum level of cartilage oligomeric matrix protein (COMP) in equine osteoarthritis. Equine Vet J. 2002;34:602–608. doi: 10.2746/042516402776180205. [DOI] [PubMed] [Google Scholar]
  96. Mittaz L., Ricardo S., Martinez G., Kola I., Kelly D.J., Little M.H., Hertzog P.J., Pritchard M.A. Neonatal calyceal dilation and renal fibrosis resulting from loss of Adamts-1 in mouse kidney is due to a developmental dysgenesis. Nephrol Dial Transplant. 2005;20:419–423. doi: 10.1093/ndt/gfh603. [DOI] [PubMed] [Google Scholar]
  97. Mittaz L., Russell D.L., Wilson T., Brasted M., Tkalcevic J., Salamonsen L.A., Hertzog P.J., Pritchard M.A. Adamts-1 is essential for the development and function of the urogenital system. Biol Reprod. 2004;70:1096–1105. doi: 10.1095/biolreprod.103.023911. [DOI] [PubMed] [Google Scholar]
  98. Moake J.L. von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura. Semin Hematol. 2004;41:4–14. doi: 10.1053/j.seminhematol.2003.10.003. [DOI] [PubMed] [Google Scholar]
  99. Moriguchi-Goto S., Yamashita A., Tamura N., Soejima K., Takahashi M., Nakagaki T., Goto S., Asada Y. ADAMTS-13 attenuates thrombus formation on type I collagen surface and disrupted plaques under flow conditions. Atherosclerosis. 2009;203:409–416. doi: 10.1016/j.atherosclerosis.2008.07.043. [DOI] [PubMed] [Google Scholar]
  100. Murphy G., Lee M.H. What are the roles of metalloproteinases in cartilage and bone damage? Ann Rheum Dis. 2005;64(Suppl4):iv44–iv47. doi: 10.1136/ard.2005.042465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Murphy G., Nagase H. Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair? Nat Clin Pract Rheumato. 2008;14:128–135. doi: 10.1038/ncprheum0727. [DOI] [PubMed] [Google Scholar]
  102. Naito S., Shiomi T., Okada A., Kimura T., Chijiiwa M., Fujita Y., Yatabe T., Komiya K., Enomoto H., Fujikawa K., et al. Expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic cartilage. Pathol Int. 2007;57:703–711. doi: 10.1111/j.1440-1827.2007.02167.x. [DOI] [PubMed] [Google Scholar]
  103. Nakada M., Miyamori H., Kita D., Takahashi T., Yamashita J., Sato H., Miura R., Yamaguchi Y., Okada Y. Human glioblastomas overexpress ADAMTS-5 that degrades brevican. Acta Neuropathol. 2005;110:239–246. doi: 10.1007/s00401-005-1032-6. [DOI] [PubMed] [Google Scholar]
  104. Nakamura A., Sakai Y., Ohata C., Komurasaki T. Expression and significance of a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)-1 in an animal model of renal interstitial fibrosis induced by unilateral ureteral obstruction. Exp Toxicol Pathol. 2007;59:1–7. doi: 10.1016/j.etp.2007.01.003. [DOI] [PubMed] [Google Scholar]
  105. Neidhart M. Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases. J Rheumatol. 1996;23:476–481. [PubMed] [Google Scholar]
  106. Neidhart M., Hauser N., Paulsson M., DiCesare P.E., Michel B.A., Hauselmann H.J. Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation. Br J Rheumatol. 1997;36:1151–1160. doi: 10.1093/rheumatology/36.11.1151. [DOI] [PubMed] [Google Scholar]
  107. Nicholson A.C., Malik S.B., Logsdon J.M., Jr., Van Meir E.G. Functional evolution of ADAMTS genes: evidence from analyses of phylogeny and gene organization. BMC Evol Biol. 2005;5:11. doi: 10.1186/1471-2148-5-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Ong C.H., Bateman A. Progranulin (granulin-epithelin precursor, PC-cell derived growth factor, acrogranin) in proliferation and tumorigenesis. Histol Histopathol. 2003;18:1275–1288. doi: 10.14670/HH-18.1275. [DOI] [PubMed] [Google Scholar]
  109. Plaas A., Osborn B., Yoshihara Y., Bai Y., Bloom T., Nelson F., Mikecz K., Sandy J.D. Aggrecanolysis in human osteoarthritis: confocal localization and biochemical characterization of ADAMTS5-hyaluronan complexes in articular cartilages. Osteoarthritis Cartilage. 2007;15:719–734. doi: 10.1016/j.joca.2006.12.008. [DOI] [PubMed] [Google Scholar]
  110. Porter S., Clark I.M., Kevorkian L., Edwards D.R. The ADAMTS metalloproteinases. Biochem J. 2005;386:15–27. doi: 10.1042/BJ20040424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Pratta M.A., Scherle P.A., Yang G., Liu R.Q., Newton R.C. Induction of aggrecanase 1 (ADAM-TS4) by interleukin-1 occurs through activation of constitutively produced protein. Arthritis Rheum. 2003;48:119–133. doi: 10.1002/art.10726. [DOI] [PubMed] [Google Scholar]
  112. Pratta M.A., Yao W., Decicco C., Tortorella M.D., Liu R.Q., Copeland R.A., Magolda R., Newton R.C., Trzaskos J.M., Arner E.C. Aggrecan protects cartilage collagen from proteolytic cleavage. J Biol Chem. 2003;278:45539–45545. doi: 10.1074/jbc.M303737200. [DOI] [PubMed] [Google Scholar]
  113. Rees S.G., Flannery C.R., Little C.B., Hughes C.E., Caterson B., Dent C.M. Catabolism of aggrecan, decorin and biglycan in tendon. Biochem J. 2000;350(Pt1):181–188. [PMC free article] [PubMed] [Google Scholar]
  114. Reginster J.Y. The efficacy of glucosamine sulfate in osteoarthritis: financial and nonfinancial conflict of interest. Arthritis Rheum. 2007;56:2105–2110. doi: 10.1002/art.22852. [DOI] [PubMed] [Google Scholar]
  115. Rehn A.P., Birch M.A., Karlstrom E., Wendel M., Lind T. ADAMTS-1 increases the three-dimensional growth of osteoblasts through type I collagen processing. Bone. 2007;41:231–238. doi: 10.1016/j.bone.2007.04.187. [DOI] [PubMed] [Google Scholar]
  116. Rintelen B., Neumann K., Leeb B.F. A meta-analysis of controlled clinical studies with diacerein in the treatment of osteoarthritis. Arch Intern Med. 2006;166:1899–1906. doi: 10.1001/archinte.166.17.1899. [DOI] [PubMed] [Google Scholar]
  117. Roach H.I., Yamada N., Cheung K.S., Tilley S., Clarke N.M., Oreffo R.O., Kokubun S., Bronner F. Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum. 2005;52:3110–3124. doi: 10.1002/art.21300. [DOI] [PubMed] [Google Scholar]
  118. Rocks N., Paulissen G., Quesada-Calvo F., Munaut C., Gonzalez M.L., Gueders M., Hacha J., Gilles C., Foidart J.M., Noel A., et al. ADAMTS-1 metalloproteinase promotes tumor development through the induction of a stromal reaction in vivo. Cancer Res. 2008;68:9541–9550. doi: 10.1158/0008-5472.CAN-08-0548. [DOI] [PubMed] [Google Scholar]
  119. Rodriguez-Lopez J., Mustafa Z., Pombo-Suarez M., Malizos K.N., Rego I., Blanco F.J., Tsezou A., Loughlin J., Gomez-Reino J.J., Gonzalez A. Genetic variation including nonsynonymous polymorphisms of a major aggrecanase, ADAMTS-5, in susceptibility to osteoarthritis. Arthritis Rheum. 2008;58:435–441. doi: 10.1002/art.23201. [DOI] [PubMed] [Google Scholar]
  120. Rodriguez-Lopez J., Pombo-Suarez M., Loughlin J., Tsezou A., Blanco F.J., Meulenbelt I., Slagboom P.E., Valdes A.M., Spector T.D., Gomez-Reino J.J., et al. Association of a nsSNP in ADAMTS14 to some osteoarthritis phenotypes. Osteoarthritis Cartilage. 2009;17:321–327. doi: 10.1016/j.joca.2008.07.012. [DOI] [PubMed] [Google Scholar]
  121. Rodriguez-Manzaneque J.C., Milchanowski A.B., Dufour E.K., Leduc R., Iruela-Arispe M.L. Characterization of METH-1/ADAMTS1 processing reveals two distinct active forms. J Biol Chem. 2000;275:33471–33479. doi: 10.1074/jbc.M002599200. [DOI] [PubMed] [Google Scholar]
  122. Rosenberg K., Olsson H., Morgelin M., Heinegard D. Cartilage oligomeric matrix protein shows high affinity zinc-dependent interaction with triple helical collagen. J Biol Chem. 1998;273:20397–20403. doi: 10.1074/jbc.273.32.20397. [DOI] [PubMed] [Google Scholar]
  123. Roughley P.J. Articular cartilage and changes in arthritis: noncollagenous proteins and proteoglycans in the extracellular matrix of cartilage. Arthritis Res. 2001;3:342–347. doi: 10.1186/ar326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Rowan A.D., Litherland G.J., Hui W., Milner J.M. Metalloproteases as potential therapeutic targets in arthritis treatment. Expert Opin Ther Targets. 2008;12:1–18. doi: 10.1517/14728222.12.1.1. [DOI] [PubMed] [Google Scholar]
  125. Roy R., Louis G., Loughlin K.R., Wiederschain D., Kilroy S.M., Lamb C.C., Zurakowski D., Moses M.A. Tumorspecific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase species. Clin Cancer Res. 2008;14:6610–6617. doi: 10.1158/1078-0432.CCR-08-1136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  126. Sabatine M.S., Ploughman L., Simonsen K.L., Iakoubova O.A., Kirchgessner T.G., Ranade K., Tsuchihashi Z., Zerba K.E., Long D.U., Tong C.H., et al. Association between ADAMTS1 matrix metalloproteinase gene variation, coronary heart disease, and benefit of statin therapy. Arterioscler Thromb Vasc Biol. 2008;28:562–567. doi: 10.1161/ATVBAHA.107.156653. [DOI] [PubMed] [Google Scholar]
  127. Sahebjam S., Khokha R., Mort J.S. Increased collagen and aggrecan degradation with age in the joints of Timp3(−/−) mice. Arthritis Rheum. 2007;56:905–909. doi: 10.1002/art.22427. [DOI] [PubMed] [Google Scholar]
  128. Sandy J.D. A contentious issue finds some clarity: on the independent and complementary roles of aggrecanase activity and MMP activity in human joint aggrecanolysis. Osteoarthritis Cartilage. 2003;14:95–100. doi: 10.1016/j.joca.2005.09.004. [DOI] [PubMed] [Google Scholar]
  129. Sandy J.D., Flannery C.R., Neame P.J., Lohmander L.S. The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain. J Clin Invest. 1992;89:1512–1516. doi: 10.1172/JCI115742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Sandy J.D., Gamett D., Thompson V., Verscharen C. Chondrocyte-mediated catabolism of aggrecan: aggrecanase-dependent cleavage induced by interleukin-1 or retinoic acid can be inhibited by glucosamine. Biochem J. 1998;335Pt1:59–66. doi: 10.1042/bj3350059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Sandy J.D., Verscharen C. Analysis of aggrecan in human knee cartilage and synovial fluid indicates that aggrecanase (ADAMTS) activity is responsible for the catabolic turnover and loss of whole aggrecan whereas other protease activity is required for C-terminal processing in vivo. Biochem J. 2001;358:615–626. doi: 10.1042/0264-6021:3580615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Sawaji Y., Hynes J., Vincent T., Saklatvala J. Fibroblast growth factor 2 inhibits induction of aggrecanase activity in human articular cartilage. Arthritis Rheum. 2008;58:3498–3509. doi: 10.1002/art.24025. [DOI] [PubMed] [Google Scholar]
  133. Saxne T., Heinegard D. Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood. Br J Rheumatol. 1992;31:583–591. doi: 10.1093/rheumatology/31.9.583. [DOI] [PubMed] [Google Scholar]
  134. Shenkman B. The role of ADAMT-13 in platelet adhesion in flow: methods for diagnosis of thrombotic thrombocytopenic purpura. Pathophysiol Haemost Thromb. 2006;35:98–102. doi: 10.1159/000093550. [DOI] [PubMed] [Google Scholar]
  135. Shindo T., Kurihara H., Kuno K., Yokoyama H., Wada T., Kurihara Y., Imai T., Wang Y., Ogata M., Nishimatsu H., et al. ADAMTS-1: a metalloproteinase-disintegrin essential for normal growth, fertility, and organ morphology and function. J Clin Invest. 2000;105:1345–1352. doi: 10.1172/JCI8635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Shozu M., Minami N., Yokoyama H., Inoue M., Kurihara H., Matsushima K., Kuno K. ADAMTS-1 is involved in normal follicular development, ovulatory process and organization of the medullary vascular network in the ovary. J Mol Endocrinol. 2005;35:343–355. doi: 10.1677/jme.1.01735. [DOI] [PubMed] [Google Scholar]
  137. Somerville R.P., Longpre J.M., Apel E.D., Lewis R.M., Wang L.W., Sanes J.R., Leduc R., Apte S.S. ADAMTS7B, the full-length product of the ADAMTS7 gene, is a chondroitin sulfate proteoglycan containing a mucin domain. J Biol Chem. 2004;279:35159–35175. doi: 10.1074/jbc.M402380200. [DOI] [PubMed] [Google Scholar]
  138. Somerville R.P., Longpre J.M., Jungers K.A., Engle J.M., Ross M., Evanko S., Wight T.N., Leduc R., Apte S.S. Characterization of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS subfamily related to Caenorhabditis elegans GON-1. J Biol Chem. 2003;278:9503–9513. doi: 10.1074/jbc.M211009200. [DOI] [PubMed] [Google Scholar]
  139. Song R.H., Tortorella M.D., Malfait A.M., Alston J.T., Yang Z., Arner E.C., Griggs D.W. Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5. Arthritis Rheum. 2007;56:575–585. doi: 10.1002/art.22334. [DOI] [PubMed] [Google Scholar]
  140. Stanton H., Rogerson F.M., East C.J., Golub S.B., Lawlor K.E., Meeker C.T., Little C.B., Last K., Farmer P.J., Campbell I.K., et al. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature. 2005;434:648–652. doi: 10.1038/nature03417. [DOI] [PubMed] [Google Scholar]
  141. Stracke J.O., Fosang A.J., Last K., Mercuri F.A., Pendas A.M., Llano E., Perris R., Di Cesare P.E., Murphy G., Knauper V. Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP) FEBS Lett. 2000;478:52–56. doi: 10.1016/s0014-5793(00)01819-6. [DOI] [PubMed] [Google Scholar]
  142. Sugimoto K., Takahashi M., Yamamoto Y., Shimada K., Tanzawa K. Identification of aggrecanase activity in medium of cartilage culture. J Biochem. 1999;126:449–455. doi: 10.1093/oxfordjournals.jbchem.a022471. [DOI] [PubMed] [Google Scholar]
  143. Takizawa M., Yatabe T., Okada A., Chijiiwa M., Mochizuki S., Ghosh P., Okada Y. Calcium pentosan polysulfate directly inhibits enzymatic activity of ADAMTS4 (aggrecanase-1) in osteoarthritic chondrocytes. FEBS Lett. 2008;582:2945–2949. doi: 10.1016/j.febslet.2008.07.036. [DOI] [PubMed] [Google Scholar]
  144. Tang B.L. ADAMTS: a novel family of extracellular matrix proteases. Int J Biochem Cell Biol. 2001;33:33–44. doi: 10.1016/s1357-2725(00)00061-3. [DOI] [PubMed] [Google Scholar]
  145. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTALW: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994;22:4673–4680. doi: 10.1093/nar/22.22.4673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  146. Tkachenko E., Rhodes J.M., Simons M. Syndecans: new kids on the signaling block. Circ Res. 2005;96:488–500. doi: 10.1161/01.RES.0000159708.71142.c8. [DOI] [PubMed] [Google Scholar]
  147. Tortorella M., Pratta M., Liu R.Q., Abbaszade I., Ross H., Burn T., Arner E. The thrombospondin motif of aggrecanase-1 (ADAMTS-4) is critical for aggrecan substrate recognition and cleavage. J Biol Chem. 2000;275:25791–25797. doi: 10.1074/jbc.M001065200. [DOI] [PubMed] [Google Scholar]
  148. Tortorella M.D., Arner E.C., Hills R., Easton A., Korte-Sarfaty J., Fok K., Wittwer A.J., Liu R.Q., Malfait A.M. Alpha2-macroglobulin is a novel substrate for ADAMTS-4 and ADAMTS-5 and represents an endogenous inhibitor of these enzymes. J Biol Chem. 2004;279:17554–17561. doi: 10.1074/jbc.M313041200. [DOI] [PubMed] [Google Scholar]
  149. Tortorella M.D., Burn T.C., Pratta M.A., Abbaszade I., Hollis J.M., Liu R., Rosenfeld S.A., Copeland R.A., Decicco C.P., Wynn R., et al. Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science. 1999;284:1664–1666. doi: 10.1126/science.284.5420.1664. [DOI] [PubMed] [Google Scholar]
  150. Tortorella M.D., Malfait A.M. Will the real aggrecanase (s) step up: evaluating the criteria that define aggrecanase activity in osteoarthritis. Curr Pharm Biotechnol. 2008;9:16–23. doi: 10.2174/138920108783497622. [DOI] [PubMed] [Google Scholar]
  151. Tortorella M.D., Malfait A.M., Deccico C., Arner E. The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation. Osteoarthritis Cartilage. 2001;9:539–552. doi: 10.1053/joca.2001.0427. [DOI] [PubMed] [Google Scholar]
  152. Tortorella M.D., Pratta M., Liu R.Q., Austin J., Ross O.H., Abbaszade I., Burn T., Arner E. Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4) J Biol Chem. 2000;275:18566–18573. doi: 10.1074/jbc.M909383199. [DOI] [PubMed] [Google Scholar]
  153. Troeberg L., Fushimi K., Khokha R., Emonard H., Ghosh P., Nagase H. Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases. FASEB J. 2008;22:3515–3524. doi: 10.1096/fj.08-112680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  154. Tsuzaki M., Guyton G., Garrett W., Archambault J.M., Herzog W., Almekinders L., Bynum D., Yang X., Banes A.J. IL-1 beta induces COX2, MMP-1, -3 and -13, ADAMTS-4, IL-1 beta and IL-6 in human tendon cells. J Orthop Res. 2003;21:256–264. doi: 10.1016/S0736-0266(02)00141-9. [DOI] [PubMed] [Google Scholar]
  155. Vankemmelbeke M.N., Holen I., Wilson A.G., Ilic M.Z., Handley C. J., Kelner G.S., Clark M., Liu C., Maki R.A., Burnett D., et al. Expression and activity of ADAMTS-5 in synovium. Eur J Biochem. 2001;268:1259–1268. doi: 10.1046/j.1432-1327.2001.01990.x. [DOI] [PubMed] [Google Scholar]
  156. Vazquez F., Hastings G., Ortega M.A., Lane T.F., Oikemus S., Lombardo M., Iruela-Arispe M.L. METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity. J Biol Chem. 1999;274:23349–23357. doi: 10.1074/jbc.274.33.23349. [DOI] [PubMed] [Google Scholar]
  157. Vlad S.C., LaValley M.P., McAlindon T.E., Felson D.T. Glucosamine for pain in osteoarthritis: why do trial results differ? Arthritis Rheum. 2007;56:2267–2277. doi: 10.1002/art.22728. [DOI] [PubMed] [Google Scholar]
  158. Voros G., Maquoi E., Collen D., Lijnen H.R. Differential expression of plasminogen activator inhibitor-1, tumor necrosis factor-alpha, TNF-alpha converting enzyme and ADAMTS family members in murine fat territories. Biochim Biophys Acta. 2003;1625:36–42. doi: 10.1016/s0167-4781(02)00589-4. [DOI] [PubMed] [Google Scholar]
  159. Wagsater D., Bjork H., Zhu C., Bjorkegren J., Valen G., Hamsten A., Eriksson P. ADAMTS-4 and -8 are inflammatory regulated enzymes expressed in macrophage-rich areas of human atherosclerotic plaques. Atherosclerosis. 2008;196:514–522. doi: 10.1016/j.atherosclerosis.2007.05.018. [DOI] [PubMed] [Google Scholar]
  160. Wayne G.J., Deng S.J., Amour A., Borman S., Matico R., Carter H. L., Murphy G. TIMP-3 inhibition of ADAMTS-4 (Aggrecanase-1) is modulated by interactions between aggrecan and the C-terminal domain of ADAMTS-4. J Biol Chem. 2007;282:20991–20998. doi: 10.1074/jbc.M610721200. [DOI] [PubMed] [Google Scholar]
  161. Westling J., Fosang A.J., Last K., Thompson V.P., Tomkinson K.N., Hebert T., McDonagh T., Collins-Racie L.A., LaVallie E.R., Morris E.A., et al. ADAMTS4 cleaves at the aggrecanase site (Glu373-Ala374) and secondarily at the matrix metalloproteinase site (Asn341-Phe342) in the aggrecan interglobular domain. J Biol Chem. 2002;277:16059–16066. doi: 10.1074/jbc.M108607200. [DOI] [PubMed] [Google Scholar]
  162. Wiberg C., Hedbom E., Khairullina A., Lamande S.R., Oldberg A., Timpl R., Morgelin M., Heinegard D. Biglycan and decorin bind close to the n-terminal region of the collagen VI triple helix. J Biol Chem. 2001;276:18947–18952. doi: 10.1074/jbc.M100625200. [DOI] [PubMed] [Google Scholar]
  163. Wiberg C., Heinegard D., Wenglen C., Timpl R., Morgelin M. Biglycan organizes collagen VI into hexagonal-like networks resembling tissue structures. J Biol Chem. 2002;277:49120–49126. doi: 10.1074/jbc.M206891200. [DOI] [PubMed] [Google Scholar]
  164. Wright W.E., Sassoon D.A., Lin V.K. Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell. 1989;56:607–617. doi: 10.1016/0092-8674(89)90583-7. [DOI] [PubMed] [Google Scholar]
  165. Xu K., Zhang Y., Ilalov K., Carlson C.S., Feng J.Q., Di Cesare P.E., Liu C.J. Cartilage oligomeric matrix protein associates with granulin-epithelin precursor (GEP) and potentiates GEP-stimulated chondrocyte proliferation. J Biol Chem. 2007;282:11347–11355. doi: 10.1074/jbc.M608744200. [DOI] [PubMed] [Google Scholar]
  166. Yamanishi Y., Boyle D.L., Clark M., Maki R.A., Tortorella M.D., Arner E.C., Firestein G.S. Expression and regulation of aggrecanase in arthritis: the role of TGF-beta. J Immunol. 2002;168:1405–1412. doi: 10.4049/jimmunol.168.3.1405. [DOI] [PubMed] [Google Scholar]
  167. Yasumoto T., Bird J.L., Sugimoto K., Mason R.M., Bayliss M.T. The G1 domain of aggrecan released from porcine articular cartilage forms stable complexes with hyaluronan/link protein. Rheumatology. 2003;42:336–342. doi: 10.1093/rheumatology/keg109. [DOI] [PubMed] [Google Scholar]
  168. Yatabe T., Mochizuki S., Takizawa M., Chijiiwa M., Okada A., Kimura T., Fujita Y., Matsumoto H., Toyama Y., Okada Y. Hyaluronan inhibits expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic chondrocytes. Ann Rheum Dis. 2009;68:1051–1058. doi: 10.1136/ard.2007.086884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  169. Yaykasli K.O., Oohashi T., Hirohata S., Hatipoglu O.F., Inagawa K., Demircan K., Ninomiya Y. ADAMTS9 activation by interleukin 1 beta via NFATc1 in OUMS-27 chondrosarcoma cells and in human chondrocytes. Mol Cell Biochem. 2009;323:69–79. doi: 10.1007/s11010-008-9965-4. [DOI] [PubMed] [Google Scholar]
  170. Zanocco-Marani T., Bateman A., Romano G., Valentinis B., He Z. H., Baserga R. Biological activities and signaling pathways of the granulin/epithelin precursor. Cancer Res. 1999;59:5331–5340. [PubMed] [Google Scholar]
  171. Zhang W., Moskowitz R.W., Nuki G., Abramson S., Altman R.D., Arden N., Bierma-Zeinstra S., Brandt K.D., Croft P., Doherty M., et al. OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage. 2007;15:981–1000. doi: 10.1016/j.joca.2007.06.014. [DOI] [PubMed] [Google Scholar]
  172. Zhou J., Gao G., Crabb J.W., Serrero G. Purification of an autocrine growth factor homologous with mouse epithelin precursor from a highly tumorigenic cell line. J Biol Chem. 1993;268:10863–10869. [PubMed] [Google Scholar]
  173. Zhu J., Nathan C., Jin W., Sim D., Ashcroft G.S., Wahl S.M., Lacomis L., Erdjument-Bromage H., Tempst P., Wright C.D., et al. Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell. 2002;111:867–878. doi: 10.1016/s0092-8674(02)01141-8. [DOI] [PubMed] [Google Scholar]

Articles from Protein & Cell are provided here courtesy of Oxford University Press

RESOURCES